These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 7547360)
1. Progress toward the development of a respiratory syncytial virus vaccine. Ewasyshyn M; Klein M Pediatr Pulmonol Suppl; 1995; 11():81-3. PubMed ID: 7547360 [No Abstract] [Full Text] [Related]
2. Protective and disease-enhancing immune responses to respiratory syncytial virus. Anderson LJ; Heilman CA J Infect Dis; 1995 Jan; 171(1):1-7. PubMed ID: 7798649 [TBL] [Abstract][Full Text] [Related]
3. Prospects for a respiratory syncytial virus vaccine. Hall CB Science; 1994 Sep; 265(5177):1393-4. PubMed ID: 7915433 [No Abstract] [Full Text] [Related]
4. [The status of research to develop new vaccines against infection caused by the respiratory syncytial virus]. Pervikov IuV; Litvinov SK Vopr Virusol; 1988; 33(5):523-9. PubMed ID: 3064426 [No Abstract] [Full Text] [Related]
5. Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology. de Waal L; Wyatt LS; Yüksel S; van Amerongen G; Moss B; Niesters HG; Osterhaus AD; de Swart RL Vaccine; 2004 Feb; 22(8):923-6. PubMed ID: 15161069 [TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus--how soon will we have a vaccine? Toms GL Arch Dis Child; 1995 Jan; 72(1):1-3. PubMed ID: 7717728 [No Abstract] [Full Text] [Related]
12. Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine. Welliver RC; Tristram DA; Batt K; Sun M; Hogerman D; Hildreth S J Infect Dis; 1994 Aug; 170(2):425-8. PubMed ID: 8035030 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Piedra PA; Cron SG; Jewell A; Hamblett N; McBride R; Palacio MA; Ginsberg R; Oermann CM; Hiatt PW; Vaccine; 2003 Jun; 21(19-20):2448-60. PubMed ID: 12744878 [TBL] [Abstract][Full Text] [Related]
14. Vaccination with RSV M Fazolo T; Gassen RB; de Freitas DN; Borges TJ; Rigo MM; da Silva RD; Maito F; Cunha A; Gasparin Bueno Mendes DA; Báfica A; Vargas JE; de Souza APD; Bonorino C Antiviral Res; 2018 Sep; 157():102-110. PubMed ID: 29990516 [TBL] [Abstract][Full Text] [Related]
15. Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins. Lee YT; Ko EJ; Kim KH; Hwang HS; Lee Y; Kwon YM; Kim MC; Lee YN; Jung YJ; Kang SM J Biomed Nanotechnol; 2017 Jan; 13(1):84-98. PubMed ID: 29302248 [TBL] [Abstract][Full Text] [Related]
16. Do recombinant-engineered nanoparticle vaccines hold promise for the prevention of respiratory syncytial virus? Lee YT; Kwon YM; Kang SM Nanomedicine (Lond); 2016; 11(5):439-42. PubMed ID: 26893211 [No Abstract] [Full Text] [Related]
17. Pathogenesis of respiratory syncytial virus vaccine-augmented pathology. Graham BS Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 2):S63-6. PubMed ID: 7551416 [TBL] [Abstract][Full Text] [Related]
18. Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis. Piedra PA; Grace S; Jewell A; Spinelli S; Hogerman DA; Malinoski F; Hiatt PW Pediatr Infect Dis J; 1998 Mar; 17(3):217-24. PubMed ID: 9535249 [TBL] [Abstract][Full Text] [Related]